1 2 Objective: To systematically review the evidence examining effects of walking 3 interventions on pain and self-reported function in individuals with chronic 4 musculoskeletal pain. Study Selection: Randomized and quasi-randomized controlled trials in adults with 9 chronic low back pain, osteoarthritis or fibromyalgia comparing walking interventions to 10 a non-exercise or non-walking exercise control group.
The meta-analysis compared mean values for pain and function between walking 139 intervention and control groups. To avoid double counting, where multiple treatment 140 groups were included walking was compared only to minimal intervention controls.
141
Suitable studies were considered to be clinically homogeneous on the basis of 142 similarities in participant demographics and intervention methods. These data were 143 pooled and analyzed using RevMan (v.5.2.8) .(25) Statistical heterogeneity was 144 assessed using the χ 2 and I 2 test statistics. Where the P value was less than 0.05 or 145 the I 2 value greater than 50%, indicating large heterogeneity,(26) a random effects 146 model for inverse variance was used to calculate the mean difference and 95%CI.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
Walking for Musculoskeletal Pain: Review 7 Formal statistical tests were not used to assess publication bias, which was evaluated 148 using visual assessment of funnel plots. Data were analyzed by length of follow-up 149 which was categorized as short (≤8 weeks post randomization), medium (2-12 months) 150 or long-term (>12 months). Sensitivity analyses were carried out excluding studies 151 where walking was combined with a co-intervention.
153
Nine articles were not included in the meta-analysis for the following reasons: no 154 validated self-reported measure of pain or function (27,28) (one study used a 155 functional scale that contained additional questions related to global health status and 156 these data were therefore not included); unadjusted baseline differences between Twenty four of the studies were randomized controlled trials. Twelve provided data for 173 31, [36] [37] [38] [39] [40] [41] [42] [43] , eight for FMS (30, (33) (34) (35) (44) (45) (46) (47) , five for CLBP (32, (48) (49) (50) (51) and 174 one included participants with chronic hip, lower back or knee pain.(52) Demographic 175 details and study characteristics are summarized in Table 1 and Table 2 .
177
In the majority of interventions (19/26, 73%) walking was supervised in a hospital 178 clinic, gymnasium or other setting (Table 2) . Some studies combined supervised 179 walking with instructions to walk at home;(31,37,40) six were home-based 180 only. (28, 30, 32, 38, 43, 51) Three used pedometers to assist with step-based walking 181 goals (28,43,51) while three used time-based walking goals. (30, 32, 38) 
183
Thirteen studies included a walking only intervention group. The remaining combined 184 walking with a co-intervention. The most common of which were educational 185 interventions or alternative forms of exercise (Table 2) . A range of controls were used 186 including education; usual care; alternative forms of exercise; a passive intervention 187 (relaxation/massage) and a 6-8 week pre-intervention baseline phase. Mean length of 188 final follow-up was 1.8 months (SD: 0.4) for studies with short term outcomes (≤8 189 weeks post randomization); 4.9 months (SD: 1.9) for medium-term outcomes (>2-12 190 months); and 18.4 months (SD: 7.6) for long-term outcomes (>12 months).
192
Eleven studies included a statement of associated adverse events. These included two 193 falls resulting in distal radial fractures, one fall resulting in a hip fracture, one case of were rated as good. (32, 33, 37, 47, 48, 51) A small number of studies (n=5) contained 204 serious potential sources of methodological bias and were therefore rated as 205 poor. (27, 28, 30, 31, 43) were rated as fair, with nine rated as good. (32, 33, 36, 38, 42, 43, 47, 50, 51 
227
data are presented here using the more conservative random effects model.
228
Analysis revealed significant differences in favour of walking interventions in terms of 229 reduced pain at short (mean difference (MD) -5.31, 95% confidence interval (95% CI)
230
-8.06 to -2.56) and medium-term follow-up (MD -7.92, 95% CI -12.37 to -3.48). No 231 effect on pain was observed for long-term data (MD -2.22, 95% CI -6.03 to 1.59)
232
( Figure 2 ). For self-reported function, improvements were found at short-term (MD -233 6.47, 95% CI -12.00 to -0.95), medium (MD -9.31, 95% CI -14.00 to -4.61) and long-234 term follow-up (MD -5.22, 95% CI -7.21 to -3.23) ( Figure 3 ). Sensitivity analyses 235 excluding studies which combined walking with a co-intervention did not alter overall 
300
We were unable to use sensitivity analysis to examine studies separately on the basis 301 of quality as only one study included in the meta-analysis contained a potential serious 302 methodological flaw which could have compromised its validity. Use of the USPSTF 303 system allowed a qualitative assessment of the overall evidence to be made, and the 304 findings and conclusions were broadly similar between this assessment method and 305 the results of the meta-analysis.
307
There are some limitations which should be taken into account when considering these 308 findings. A small number of studies had methodological limitations, including 309 inadequate allocation concealment in randomized controlled trials or lack of an 310 appropriate method for dealing with missing data. In six studies there was insufficient 311 information on masking of outcome assessments and with additional information it is 312 possible that some studies rated as "fair" may have been rated as "poor" which would American College of Sports Medicine (ACSM) criteria for assessment of the adequacy of exercise interventions in individual studies: (1) Frequency of exercise of at least three days per week or twice a week for deconditioned individuals.
(2) Intensity of exercise sufficient to achieve equal to or greater than 40% of heart rate reserve (min-max: 40-85%) or 64% of predicted maximum heart rate (min-max: 64-94%).
(3) Sessions of at least 20 minutes duration (min-max: 20-60 minutes), either as continuous exercise or spread intermittently throughout the day in blocks of 10 minutes or more. (4) 
